Insulet (PODD) Common Equity (2010 - 2026)
Insulet's (PODD) quarterly Common Equity came in at $1.3 billion in Q1 2026, down 2.1% YoY from $1.3 billion in Q1 2025, and down 14.03% on a QoQ basis from $1.5 billion in Q4 2025.
Insulet (PODD) Common Equity (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Common Equity data on file, last reported at $1.3 billion in Q1 2026.
- Quarterly Common Equity fell 2.1% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 2.1% YoY) and the FY2025 annual result came in at $1.5 billion, up 25.06% from the prior year.
- Common Equity slipped to $1.3 billion in Q1 2026, from $1.5 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $422.4 million in Q2 2022.
- A 5-year average of $899.1 million and a median of $790.7 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity declined 23.68% — and 2024, when it soared 84.03%.
- Tracing PODD's Common Equity over 5 years: stood at $476.4 million in 2022, then jumped by 53.8% to $732.7 million in 2023, then jumped by 65.36% to $1.2 billion in 2024, then climbed by 25.06% to $1.5 billion in 2025, then dropped by 14.03% to $1.3 billion in 2026.
- The last three Common Equity figures came in at $1.3 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Insulet | 10.36 Bn | 9.82 Bn | 562.60 Mn | 1.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Bn |
| Mar 31, 2026 | 1.30 Bn |
| Dec 31, 2025 | 1.52 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.33 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 998.40 Mn |
| Mar 31, 2024 | 790.70 Mn |
| Dec 31, 2023 | 732.70 Mn |
| Sep 30, 2023 | 607.50 Mn |
| Jun 30, 2023 | 553.90 Mn |
| Mar 31, 2023 | 502.80 Mn |
| Dec 31, 2022 | 476.40 Mn |
| Sep 30, 2022 | 428.00 Mn |
| Jun 30, 2022 | 422.40 Mn |
| Mar 31, 2022 | 446.70 Mn |
| Dec 31, 2021 | 556.30 Mn |
| Sep 30, 2021 | 497.90 Mn |